Long term treatment of postmenopausal osteoporosis with calcitonin, alendronate, or alphacalcidiol

被引：0
作者：
Demirel, GG [1 ]
Paker, N [1 ]
Yilmaz, H [1 ]
机构：
[1] Istanbul Phys Med & Rehabil Ctr, Istanbul, Turkey
来源：
OSTEOPOROSIS INTERNATIONAL | 2000年 / 11卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
466
引用
收藏
页码：S181 / S181
页数：1
相关论文
共 50 条
  • [21] Effects of long-term alendronate treatment on postmenopausal osteoporosis bone material properties
    N. Hassler
    S. Gamsjaeger
    B. Hofstetter
    W. Brozek
    K. Klaushofer
    E. P. Paschalis
    Osteoporosis International, 2015, 26 : 339 - 352
  • [22] Alendronate in the treatment of postmenopausal osteoporosis
    Hosking, DJ
    Favus, M
    Yates, AJ
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 1999, : 27 - 35
  • [23] The effect of raloxifene after discontinuation of long-term alendronate treatment of postmenopausal osteoporosis
    Michalská, D
    Stepan, JJ
    Basson, BR
    Pavo, I
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (03) : 870 - 877
  • [24] Alendronate vs intranasal calcitonin for treatment of osteoporosis in postmenopausal women: 2 Year results
    Downs, RW
    Bell, NH
    Walsh, B
    Ettinger, MP
    Mako, B
    Smith, ME
    Wang, L
    Yates, J
    Melton, ME
    Palmisano, J
    BONE, 2001, 28 (05) : S229 - S229
  • [25] Alendronate vs. calcitonin: 2-year treatment of osteoporosis in postmenopausal women
    Rosen, CJ
    Schnitzer, TJ
    McClung, M
    Miller, PD
    Wang, L
    Vanaman, LK
    Yates, J
    Melton, ME
    Palmisano, J
    BONE, 2001, 28 (05) : S226 - S226
  • [26] Etidronate and alendronate in the treatment of postmenopausal osteoporosis
    Beauchesne, MF
    Miller, PF
    ANNALS OF PHARMACOTHERAPY, 1999, 33 (05) : 587 - 599
  • [27] LONG-TERM TREATMENT WITH CALCITONIN IN OSTEOPOROSIS
    GENNARI, C
    AGNUSDEI, D
    CAMPOREALE, A
    HORMONE AND METABOLIC RESEARCH, 1993, 25 (09) : 484 - 485
  • [28] Long-term experience with alendronate in the treatment of osteoporosis
    Hochberg, Marc C.
    Rizzoli, Rene
    EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (09) : 1201 - 1210
  • [29] Long-term effects of a six month treatment course with oral alendronate in postmenopausal osteoporosis.
    Rossini, M
    Gatti, D
    Zamberlan, N
    Braga, V
    Gerardi, D
    Adami, S
    JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : S469 - S469
  • [30] Long-term (seven-year) efficacy and safety of alendronate in the treatment of osteoporosis in postmenopausal women
    Tonino, RP
    Meunier, PJ
    Emkey, RD
    Rodriguez-Portales, JA
    Menkes, CJ
    Wasnich, RD
    Bone, HG
    Santora, AC
    Wu, M
    Desai, R
    Ross, PD
    OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S202 - S202
12345